Hybrid Capture II Detection of Oncogenic Human Papillomavirus: a Useful Tool when Evaluating Men Who Have Sex with Men with Atypical Squamous Cells of Undetermined Significance on Anal Cytology
Overview
Affiliations
Purpose: In the cervix and anus, patients with atypical squamous cells of undetermined significance often do not have high-grade squamous intraepithelial lesions. In women with atypical squamous cells of undetermined significance, Hybrid-Capture II testing for oncogenic high-risk human papillomavirus is performed and those without high-risk human papillomavirus often are observed. We endeavored to determine whether Hybrid-Capture II testing would be beneficial in men who have sex with men with atypical squamous cells of undetermined significance.
Methods: We performed a retrospective chart review of men who have sex with men with atypical squamous cells of undetermined significance who had high-resolution anoscopy and Hybrid-Capture II.
Results: A total of 290 men were identified (mean age, 42 years), and 212 (73 percent) were HIV-negative. High-grade squamous intraepithelial lesions were found in 50 (17 percent): 23 (10 percent) who were HIV-negative and 27 (35 percent) who were HIV-positive men. High-risk human papillomavirus was found in 138 (48 percent); 91 (43 percent) of HIV-negative and 47 (60 percent) of HIV-positive men. The sensitivity, specificity, positive predictive value, and negative predictive value of atypical cells of undetermined significance cytology combined with Hybrid-Capture II were 84, 60, 30, and 95 percent, respectively. There was no significant difference between all men vs. those who were HIV-positive or HIV-negative except for the positive predictive value.
Conclusions: Hybrid-Capture II testing for high-risk human papillomavirus in men who have sex with men with atypical cells of undetermined significance and referring only those with high-risk human papillomavirus reduces the number who require high-resolution anoscopy by more than half. Five percent with high-grade squamous intraepithelial lesions would be missed.
Singhartinger F, Gantschnigg A, Holzinger J, Wagner A, Singhartinger J, Koch O Tech Coloproctol. 2023; 28(1):18.
PMID: 38102514 PMC: 10724311. DOI: 10.1007/s10151-023-02896-x.
Ordonez-Blanco I, Martinez-Vernaza S, Blair K, Quiroga C, Lowenstein E, Lombana Amaya L Int J STD AIDS. 2022; 33(7):701-708.
PMID: 35491739 PMC: 10430884. DOI: 10.1177/09564624221097742.
Brown B, Davtyan M, Galea J, Chow E, Leon S, Klausner J Viruses. 2012; 4(12):3851-8.
PMID: 23250451 PMC: 3528294. DOI: 10.3390/v4123851.
Risk factors for abnormal anal cytology over time in HIV-infected women.
Baranoski A, Tandon R, Weinberg J, Huang F, Stier E Am J Obstet Gynecol. 2012; 207(2):107.e1-8.
PMID: 22520651 PMC: 3408557. DOI: 10.1016/j.ajog.2012.03.030.
Management of anal squamous intraepithelial lesions.
Pineda C, Welton M Clin Colon Rectal Surg. 2010; 22(2):94-101.
PMID: 20436833 PMC: 2780238. DOI: 10.1055/s-0029-1223840.